T1	Participants 64 101	women with polycystic ovary syndrome.
T2	Participants 263 340	women with clomiphene citrate (CC)-resistant polycystic ovary syndrome (PCOS)
T3	Participants 350 391	Thirty-seven women with CC-resistant PCOS
T4	Participants 994 1009	metformin group
T5	Participants 1445 1473	women with CC-resistant PCOS
